Back to article: Fecal gelatinase does not predict mortality in patients with alcohol-associated hepatitis
FIGURE 1: Fecal gelatinase does not predict 30-day or 90-day mortality in patients with alcohol-associated hepatitis. (A) Kaplan-Meier curve for 30-day survival in gelatinase positive and gelatinase negative patients with alcohol-associated hepatitis. (B) Kaplan-Meier curve for 90-day survival in gelatinase positive and gelatinase negative patients with alcohol-associated hepatitis. (C) ROC curves of liver disease markers for 30-day mortality in patients with alcohol-associated hepatitis. (D) ROC curves of liver disease markers for 90-day mortality in patients with alcohol-associated hepatitis (Gelatinase n=60, Child-Pugh n=57, FIB-4 n=57, Maddrey’s DF n=52, ABIC n=59, MELD score n=59, and MELD-Na score n=59). ABIC, ‘Age, serum bilirubin, INR, and serum creatinine score’; FIB-4, Fibrosis-4 Index; INR, international normalized ratio; Maddrey’s DF, Maddrey’s Discriminant Function; MELD, model for end-stage liver disease; MELD-Na, sodium-adjusted model for end-stage liver disease; ROC, receiver operating characteristic.